Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-25 Sale |
2022-02-28 5:18 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
7,572 | $230.98 | $1,748,990 | 36,077 (Direct) |
View |
| 2022-02-18 Sale |
2022-02-22 5:03 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
519 | $231 | $119,889 | 53,104 (Direct) |
View |
| 2022-02-18 Sale |
2022-02-22 4:51 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,312 | $230.97 | $995,949 | 49,687 (Direct) |
View |
| 2022-02-14 Sale |
2022-02-16 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,444 | $232.02 | $567,057 | 57,438 (Direct) |
View |
| 2022-02-11 Sale |
2022-02-14 4:22 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
290 | $235.09 | $68,175 | 57,737 (Direct) |
View |
| 2022-02-11 Sale |
2022-02-14 4:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,297 | $235.02 | $539,837 | 59,882 (Direct) |
View |
| 2022-02-02 Sale |
2022-02-03 4:29 pm |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
2,944 | $250.07 | $736,206 | 57,435 (Direct) |
View |
| 2022-02-02 Sale |
2022-02-03 4:26 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
1,040 | $250.98 | $261,017 | 54,952 (Direct) |
View |
| 2022-02-02 Sale |
2022-02-03 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,660 | $251.47 | $1,171,842 | 65,697 (Direct) |
View |
| 2022-01-28 Sale |
2022-02-01 4:09 pm |
VERTEX PHARMACEUTICALS INC | VRTX | MCGLYNN MARGARET G Director |
5,000 | $241.79 | $1,208,960 | 16,099 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-24 Tax Withholding |
2022-02-28 5:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy SVP, General Counsel |
1,554 | $227.86 | 14,454 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 5:23 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
12,141 | $227.86 | 90,389 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 5:21 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
7,246 | $227.86 | 122,842 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 5:20 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
1,242 | $227.86 | 49,823 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 5:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
7,246 | $227.86 | 65,206 (Direct) |
View |
| 2022-02-24 Tax Withholding |
2022-02-28 5:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
6,038 | $227.86 | 36,077 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 5:04 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
3,439 | $232.51 | 51,562 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 5:03 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
4,114 | $232.51 | 53,104 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 5:02 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
3,439 | $232.51 | 50,534 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 5:01 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
3,497 | $232.51 | 72,033 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 4:59 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy SVP, General Counsel |
712 | $232.51 | 16,008 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 4:57 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
8,236 | $232.51 | 102,530 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 4:56 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
8,584 | $232.51 | 130,088 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 4:55 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
3,439 | $232.51 | 51,065 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 4:54 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
4,126 | $232.51 | 72,452 (Direct) |
View |
| 2022-02-17 Tax Withholding |
2022-02-22 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,439 | $232.51 | 49,687 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
2,434 | $237.74 | 55,001 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:22 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
1,230 | $237.74 | 57,737 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:21 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
979 | $237.74 | 53,973 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:20 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
2,491 | $237.74 | 75,530 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy SVP, General Counsel |
474 | $237.74 | 16,720 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:16 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
3,031 | $237.74 | 138,672 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
2,437 | $237.74 | 54,504 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3,040 | $237.74 | 76,578 (Direct) |
View |
| 2022-02-10 Tax Withholding |
2022-02-14 4:11 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
3,518 | $237.74 | 59,882 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:29 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
25,588 | $0 | 57,435 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:27 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
27,714 | $0 | 59,257 (Direct) |
View |
| 2022-02-01 Tax Withholding |
2022-02-03 4:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
526 | $243.64 | 54,952 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
23,942 | $0 | 54,952 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, Chief Patient Officer |
29,638 | $0 | 78,021 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:21 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy SVP, General Counsel |
8,941 | $0 | 17,194 (Direct) |
View |
| 2022-02-02 Tax Withholding |
2022-02-03 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
6,279 | $243.63 | 110,766 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:19 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
66,817 | $0 | 110,766 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
67,949 | $0 | 141,703 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
23,988 | $0 | 56,941 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
38,375 | $0 | 79,618 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:09 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
2,566 | $0 | 3,960 (Direct) |
View |
| 2022-02-02 Exercise |
2022-02-03 4:06 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,660 | $86.52 | 65,697 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
32,108 | $0 | 65,697 (Direct) |
View |
| 2022-01-28 Exercise |
2022-02-01 4:09 pm |
N/A 2025-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | MCGLYNN MARGARET G Director |
5,000 | $127.54 | 16,099 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
190 | $230.58 | 13,672 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 4:21 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
119 | $230.58 | 794 (Direct) |
View |